Read, Learn, Innovate: Top Blog Posts from March 2020
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from March 2020. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.
ISPE Is Here for You: Supporting Your Knowledge & Connectivity Needs
As we continue to monitor the COVID-19 pandemic, our thoughts are with our Members and those impacted. We recognize that the ever-changing impact of this novel virus is disruptive to so many aspects of our personal and professional lives. We are not insulated from these disruptions; but I want to assure you that ISPE is here to support your knowledge and connectivity needs.
GAMP® Pragmatic Quality & Risk-Based Approaches: Part 2 Infrastructure - Embrace Automation
This Blog focuses on the topic of infrastructure, covering recommendations made by an FDA / industry team linked to the FDA Case for Quality initiative, and the GAMP re-examination of approaches to infrastructure.
COVID-19: Treatment and Vaccine Development Move Ahead
The pharmaceutical industry’s work on developing treatments and vaccines for COVID-19 (novel coronavirus) is moving forward, including these recent developments:
- Gilead’s remdesivir treatment is in clinical trial in China, and the company announced it is expanding clinical trials outside of China.
- Moderna has shipped the first batch of its mRNA-1273 to the National Institute of Allergy and Infectious Diseases (NIAID).
Advance Your Pharma Supply Chain Planning during a Pandemic
One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.
Drug Shortages: What to Know during the COVID-19 Outbreak
ISPE places the health and safety of its members, staff, and the broader ISPE global community as its top priority. As the COVID-19 outbreak continues, the ISPE Drug Shortages Initiatives Team encourages everyone to follow the available safety and health guidance applicable to your communities. Additionally, ISPE has a long-standing commitment to preventing and mitigating drug shortages.
About the Author
